Assessing the Impact of a Genomic Classifier on Post-Operative Physician Decision-Making for Prostate Cancer Patients in Contemporary Clinical Management. In 14th Annual Meeting of the Society of Urologic Oncology (SUO). presented at the 04/12/2013, Bethesda, MD. Retrieved from http://www.urotoday.com/Conferences/SUO-2013/. (2013).
Decreased Risk of Renal Allograft Thrombosis Associated With Interleukin-2 Receptor Antagonists: A Report of the NAPRTCS. Am J Transplant, 6, 585-588. presented at the 03/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16468970. (2006).
Decreased risk of renal allograft thrombosis associated with interleukin-2 receptor antagonists: a report of the NAPRTCS. Am J Transplant, 6(3), 585-8. presented at the 2006 Mar. doi:10.1111/j.1600-6143.2005.01213.x. (2006).
Effect of a Genomic Classifier Test on Clinical Practice Decisions for Patients with High-Risk Prostate Cancer After Surgery. BJU Int. presented at the 04/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24784420. (2014).
Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation, 63(9), 1263-7. presented at the 1997 May 15. doi:10.1097/00007890-199705150-00012. (1997).